Lista de obras - Britta Wahren - Dominio Público Uruguay

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

article

A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients

scientific article published on 30 December 2010

A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines

artículo científico publicado en 2012

A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo

artículo científico publicado en 2003

A multiplex real-time PCR for quantification of HIV-1 DNA and the human albumin gene in CD4+ cells.

artículo científico publicado en 2003

A nonsense mutation (428G-->A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection

artículo científico publicado en 2006

A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations

article

A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro

scientific article (publication date: 2012)

A novel potent strategy for induction of immunity to HIV-1 reverse transcriptase in primates

scientific article published on 01 September 2002

A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicity

artículo científico publicado en 2013

Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells

artículo científico publicado en 2011

Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques

artículo científico publicado en 2009

Autologous cytotoxicity of natural killer cells derived from HIV-infected patients

artículo científico publicado en 2004

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial

artículo científico publicado en 2016

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees

artículo científico publicado en 2013

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania ⬇️

artículo científico publicado el 22 de agosto de 2011

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

artículo científico publicado en 2008

Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.

artículo científico publicado en 2006

Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge

article

Choosing CCR5 or Rev siRNA in HIV-1

artículo científico publicado en 2003

Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation

artículo científico publicado en 2011

Correction: Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

artículo científico publicado en 2010

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.

artículo científico publicado en 2005

DNA Vaccines: Recent Developments and the Future.

artículo científico publicado en 2014

DNA mucosal HIV vaccine in humans

artículo científico publicado en 2002

DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes

artículo científico publicado en 2002

DNA vaccines for HIV/AIDS.

scientific article published on July 2006

DNA vaccines: progress and challenges

artículo científico publicado en 2005

DNA vaccines: recent developments and future possibilities

artículo científico publicado en 2006

DNA vaccines: recent technological and clinical advances.

artículo científico publicado en 2006

Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants

artículo científico publicado en 2008

Demonstration of neutralizing mucosal IgA response to intranasal HIV-1 env DNA vaccines with or without the V3 glycosylation site

artículo científico publicado en 2004

Detection of pancreatic cancer using antibody microarray-based serum protein profiling

scientific article published on 01 June 2008

Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission

artículo científico publicado en 2015

Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection

article

Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.

artículo científico publicado en 2006

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

artículo científico publicado en 2002

Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model

artículo científico publicado en 2006

Gene immunization may induce secondary antibodies reacting with DNA.

artículo científico publicado en 2004

Gene-based vaccines: recent technical and clinical advances

artículo científico publicado en 2006

Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo.

artículo científico publicado en 2004

HIV immunology better understood and vaccination attempts started: Overview ⬇️

artículo científico publicado el 1 de enero de 2002

HIV subtypes and recombination strains--strategies for induction of immune responses in man.

artículo científico publicado en 2002

HIV type 1 DNA development during long-term supervised therapy interruption.

artículo científico publicado en 2003

HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response

artículo científico publicado en 2008

HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1.

artículo científico publicado en 2005

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

artículo científico publicado en 2015

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses

artículo científico publicado en 2004

Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruption

artículo científico publicado en 2006

Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination

artículo científico publicado en 2008

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.

artículo científico publicado en 2007

Immunization with HIV protease peptides linked to syngeneic erythrocytes.

artículo científico publicado en 2007

Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses

artículo científico publicado en 2012

Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration

artículo científico publicado en 2012

Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization.

artículo científico publicado en 2005

Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity

article

Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes

artículo científico publicado en 2009

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

artículo científico publicado en 2002

Intracellular targeting of CEA results in Th1-type antibody responses following intradermal genetic vaccination by a needle-free jet injection device.

artículo científico publicado en 2007

Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity

artículo científico publicado en 2004

Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses

artículo científico publicado en 2008

Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen

artículo científico publicado en 2009

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

artículo científico publicado en 2005

Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication.

artículo científico publicado en 2004

Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization

artículo científico publicado en 2008

Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).

artículo científico publicado en 2004

Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins

artículo científico publicado en 2000

Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study

artículo científico publicado en 2006

Minor nef gene alterations after human HIV-DNA immunisation

scientific article published on 01 March 2004

Molecular analysis and phylogenetic characterization of HIV in Iran

artículo científico publicado en 2006

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.

artículo científico publicado en 2004

Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery

artículo científico publicado en 2005

Murine models for HIV vaccination and challenge.

artículo científico publicado en 2008

Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.

artículo científico publicado en 2004

NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients

artículo científico publicado en 2009

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.

artículo científico publicado en 2011

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

artículo científico publicado en 2004

Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells

artículo científico publicado en 2009

Parvovirus B19 infection: association with third-trimester intrauterine fetal death

article by L Skjöldebrand-Sparre et al published April 2000 in BJOG: an International Journal of Obstetrics and Gynaecology

Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda

artículo científico publicado en 2002

Point mutations induced by foscarnet (PFA) in the human cytomegalovirus DNA polymerase

artículo científico publicado en 2003

Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients

artículo científico publicado en 1996

Potent cross-reactive immune response against the wild-type and drug-resistant forms of HIV reverse transcriptase after the chimeric gene immunization.

artículo científico publicado en 2010

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

artículo científico publicado en 2015

Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen

artículo científico publicado en 2017

Primary murine cells as a model for HIV-1 infection.

artículo científico publicado en 2004

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial

artículo científico publicado en 2015

Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

artículo científico publicado en 2010

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.

artículo científico publicado en 2012

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.

artículo científico publicado en 2011

Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity

artículo científico publicado en 2012

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

artículo científico publicado en 2009

Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine

article

Regulatory T cell abundance and activation status before and after priming with HIVIS-DNA and boosting with MVA-HIV/rgp140/GLA-AF may impact the magnitude of the vaccine-induced immune responses

article

Responses of mice immunized with a DNA vaccine encoding carcinoembryonic antigen (CEA)

article

Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model.

artículo científico publicado en 2004

Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).

artículo científico publicado en 2011

Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice

artículo científico publicado en 2008

Sexually transmitted herpes simplex viruses

artículo científico publicado en 2004

Short communication: HIV-1 Nef protein carries multiple epitopes suitable for induction of cellular immunity for an HIV vaccine in Africa

artículo científico publicado en 2014

Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness

artículo científico publicado en 2013

Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system

scientific article published on 01 May 2003

Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment

artículo científico publicado en 2009

Strong HIV-specific CD4+ and CD8+ T-lymphocyte proliferative responses in healthy individuals immunized with an HIV-1 DNA vaccine and boosted with recombinant modified vaccinia virus ankara expressing HIV-1 genes

artículo científico publicado en 2010

Subtypes A, C, G, and recombinant HIV type 1 are circulating in Bangladesh

artículo científico publicado en 2002

Support for the RV144 HIV vaccine trial.

artículo científico publicado en 2004

The PEDVAC trial: preliminary data from the first therapeutic DNA vaccination in HIV-infected children

artículo científico publicado en 2011

Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC)

artículo científico publicado en 2013

Therapeutic immunization for HIV.

artículo científico publicado en 2006

Therapeutic vaccination against HIV.

artículo científico publicado en 2004

Three-Year Durability of Immune Responses Induced by HIV-DNA and HIV-Modified Vaccinia Virus Ankara and Effect of a Late HIV-Modified Vaccinia Virus Ankara Boost in Tanzanian Volunteers

artículo científico publicado en 2016

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.

artículo científico publicado en 2004

Vaccine delivery methods using viral vectors

artículo científico publicado en 2007

[Smallpox--eradicated disease and a potential terrorist weapon]

artículo científico publicado en 2002

Lista de obras de Britta Wahren

A New Multi-clade DNA Prime/Recombinant MVA Boost Vaccine Induces Broad and High Levels of HIV-1-specific CD8+ T-cell and Humoral Responses in Mice

A Phase I safety study of plasmid DNA immunization targeting carcinoembryonic antigen in colorectal cancer patients

A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines

A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo

A multiplex real-time PCR for quantification of HIV-1 DNA and the human albumin gene in CD4+ cells.

A nonsense mutation (428G-->A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection

A novel DNA adjuvant, N3, enhances mucosal and systemic immune responses induced by HIV-1 DNA and peptide immunizations

A novel class of anti-HIV agents with multiple copies of enfuvirtide enhances inhibition of viral replication and cellular transmission in vitro

A novel potent strategy for induction of immunity to HIV-1 reverse transcriptase in primates

A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicity

Accumulation and activation of natural killer cells in local intraperitoneal HIV-1/MuLV infection results in early control of virus infected cells

Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian-human immunodeficiency virus strain 89.6p-infected macaques

Autologous cytotoxicity of natural killer cells derived from HIV-infected patients

Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania ⬇️

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.

Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge

Choosing CCR5 or Rev siRNA in HIV-1

Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation

Correction: Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.

DNA Vaccines: Recent Developments and the Future.

DNA mucosal HIV vaccine in humans

DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes

DNA vaccines for HIV/AIDS.

DNA vaccines: progress and challenges

DNA vaccines: recent developments and future possibilities

DNA vaccines: recent technological and clinical advances.

Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants

Demonstration of neutralizing mucosal IgA response to intranasal HIV-1 env DNA vaccines with or without the V3 glycosylation site

Detection of pancreatic cancer using antibody microarray-based serum protein profiling

Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission

Elevated levels of serum perforin in chronic HIV-1 and acute SIV/SHIV infection

Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model

Gene immunization may induce secondary antibodies reacting with DNA.

Gene-based vaccines: recent technical and clinical advances

Genetic immunization with multiple HIV-1 genes provides protection against HIV-1/MuLV pseudovirus challenge in vivo.

HIV immunology better understood and vaccination attempts started: Overview ⬇️

HIV subtypes and recombination strains--strategies for induction of immune responses in man.

HIV type 1 DNA development during long-term supervised therapy interruption.

HIV-1 reverse transcriptase artificially targeted for proteasomal degradation induces a mixed Th1/Th2-type immune response

HIV-1 reverse transcriptase targeted for proteasomal degradation as a prototype vaccine against drug-resistant HIV-1.

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial

HPV-16 L1 genes with inactivated negative RNA elements induce potent immune responses

Human immunodeficiency virus-type 1 specific cellular immunity in chronic infected patients on prolonged highly active antiretroviral treatment and on structured treatment interruption

Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination

Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: study of immunological memory and long-term toxicology.

Immunization with HIV protease peptides linked to syngeneic erythrocytes.

Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses

Immunogenicity of HIV virus-like particles in rhesus macaques by intranasal administration

Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunization.

Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity

Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes

Induction of HIV-1-specific immunity after vaccination with apoptotic HIV-1/murine leukemia virus-infected cells.

Intracellular targeting of CEA results in Th1-type antibody responses following intradermal genetic vaccination by a needle-free jet injection device.

Intranasal HIV-1-gp160-DNA/gp41 peptide prime-boost immunization regimen in mice results in long-term HIV-1 neutralizing humoral mucosal and systemic immunity

Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses

Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen

Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

Locked nucleic acid containing antisense oligonucleotides enhance inhibition of HIV-1 genome dimerization and inhibit virus replication.

Long-term increase of CD4+ central memory cells in HIV-1-infected individuals by therapeutic HIV-1 rgp160 immunization

Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).

Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins

Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study

Minor nef gene alterations after human HIV-DNA immunisation

Molecular analysis and phylogenetic characterization of HIV in Iran

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.

Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery

Murine models for HIV vaccination and challenge.

Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.

NK cell activation by KIR-binding antibody 1-7F9 and response to HIV-infected autologous cells in viremic and controller HIV-infected patients

NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.

Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.

Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells

Parvovirus B19 infection: association with third-trimester intrauterine fetal death